10-Q Filing

MERCK & CO., INC. CIK: 310158 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0000310158-17-000037`
Period End Date	20170630
Filing Date	20170808
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	mrk-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 60 Cash Flow Statement 58 Comprehensive Income 28

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$195.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$200.00M	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.08B	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.12B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.51B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.52B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$15.75B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.38B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.61B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.79B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$4.18B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$7.83B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $200 in 2017 and $195 in 2016)	`AccountsReceivableNetCurrent`	$7.44B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $200 in 2017 and $195 in 2016)	`AccountsReceivableNetCurrent`	$7.02B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Inventories (excludes inventories of $1,076 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5)	`InventoryNet`	$5.41B	USD	Point-in-time
Inventories (excludes inventories of $1,076 in 2017 and $1,117 in 2016 classified in Other assets - see Note 5)	`InventoryNet`	$4.87B	USD	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	849.97M	shares	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$4.39B	USD	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	828.37M	shares	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$3.35B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$30.61B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.17B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$11.42B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$12.14B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,375 in 2017 and $15,749 in 2016	`PropertyPlantAndEquipmentNet`	$12.09B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,375 in 2017 and $15,749 in 2016	`PropertyPlantAndEquipmentNet`	$12.03B	USD	Point-in-time
Goodwill	`Goodwill`	$18.36B	USD	Point-in-time
Goodwill	`Goodwill`	$18.16B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$17.30B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$16.12B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$5.85B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$5.93B	USD	Point-in-time
Total Assets	`Assets`	$92.80B	USD	Point-in-time
Total Assets	`Assets`	$95.38B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$568.00M	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$3.18B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$2.93B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$2.81B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$9.36B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$10.27B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.98B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.24B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.32B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.30B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.76B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.20B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$24.27B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$21.71B	USD	Point-in-time
Deferred Income Taxes	`DeferredTaxLiabilitiesNoncurrent`	$5.08B	USD	Point-in-time
Deferred Income Taxes	`DeferredTaxLiabilitiesNoncurrent`	$4.56B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$8.51B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$8.07B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016	`CommonStockValue`	$1.79B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2017 and 2016	`CommonStockValue`	$1.79B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.78B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.94B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$44.13B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$45.05B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.23B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.09B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$81.52B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$80.63B	USD	Point-in-time
Less treasury stock, at cost: 849,974,743 shares in 2017 and 828,372,200 shares in 2016	`TreasuryStockValue`	$40.55B	USD	Point-in-time
Less treasury stock, at cost: 849,974,743 shares in 2017 and 828,372,200 shares in 2016	`TreasuryStockValue`	$42.05B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$39.46B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$40.09B	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$249.00M	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$220.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.77B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$43.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$40.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$39.71B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$95.38B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$92.80B	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Sales	`SalesRevenueGoodsNet`	$9.84B	USD	1 Quarter
Sales	`SalesRevenueGoodsNet`	$9.93B	USD	1 Quarter
Sales	`SalesRevenueGoodsNet`	$19.16B	USD	2 Qtrs
Sales	`SalesRevenueGoodsNet`	$19.36B	USD	2 Qtrs
Materials and production	`CostOfGoodsSold`	$6.09B	USD	2 Qtrs
Materials and production	`CostOfGoodsSold`	$7.15B	USD	2 Qtrs
Materials and production	`CostOfGoodsSold`	$3.58B	USD	1 Quarter
Materials and production	`CostOfGoodsSold`	$3.08B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$4.85B	USD	2 Qtrs
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$4.78B	USD	2 Qtrs
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.46B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.44B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.81B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.54B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.75B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.15B	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$166.00M	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$134.00M	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$317.00M	USD	2 Qtrs
Restructuring costs	`RestructuringCharges`	$225.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-58.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-117.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-67.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-19.00M	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$7.49B	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$14.92B	USD	2 Qtrs
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$16.03B	USD	2 Qtrs
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$8.34B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.44B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.50B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.13B	USD	2 Qtrs
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.44B	USD	2 Qtrs
Taxes on Income	`IncomeTaxExpenseBenefit`	$488.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$295.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$789.00M	USD	2 Qtrs
Taxes on Income	`IncomeTaxExpenseBenefit`	$935.00M	USD	2 Qtrs
Net Income	`ProfitLoss`	$3.51B	USD	2 Qtrs
Net Income	`ProfitLoss`	$2.34B	USD	2 Qtrs
Net Income	`ProfitLoss`	$1.95B	USD	1 Quarter
Net Income	`ProfitLoss`	$1.21B	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	2 Qtrs
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.00M	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.95B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.50B	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$2.33B	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.21B	USD	1 Quarter
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.71	USD	1 Quarter
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.28	USD	2 Qtrs
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.84	USD	2 Qtrs
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.44	USD	1 Quarter
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.27	USD	2 Qtrs
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.71	USD	1 Quarter
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.83	USD	2 Qtrs
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.43	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.47	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.92	USD	2 Qtrs
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.46	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.94	USD	2 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$3.51B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.34B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.95B	USD	1 Quarter
Net income	`ProfitLoss`	$1.21B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.35B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.11B	USD	2 Qtrs
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$567.00M	USD	2 Qtrs
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$131.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-272.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-120.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$148.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$156.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$80.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$82.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-63.00M	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$-166.00M	USD	2 Qtrs
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.44B	USD	2 Qtrs
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.34B	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$3.60B	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$3.77B	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$732.00M	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$654.00M	USD	2 Qtrs
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$6.28B	USD	2 Qtrs
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$6.36B	USD	2 Qtrs
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$9.36B	USD	2 Qtrs
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$7.39B	USD	2 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$347.00M	USD	2 Qtrs
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$157.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-62.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-21.00M	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$2.07B	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$243.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-9.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-24.00M	USD	2 Qtrs
Payments on debt	`RepaymentsOfLongTermDebt`	$2.35B	USD	2 Qtrs
Payments on debt	`RepaymentsOfLongTermDebt`	$301.00M	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$2.15B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.57B	USD	2 Qtrs
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$2.60B	USD	2 Qtrs
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$2.58B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$408.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$381.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-101.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-86.00M	USD	2 Qtrs
Net Cash Used in Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.76B	USD	2 Qtrs
Net Cash Used in Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.23B	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$359.00M	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$300.00M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.27B	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.92B	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$6.51B	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$8.52B	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$6.61B	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Year	`CashAndCashEquivalentsAtCarryingValue`	$7.79B	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$6.51B	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$8.52B	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$6.61B	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$7.79B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.95B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.50B	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$2.33B	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.21B	USD	1 Quarter
Net unrealized loss on derivatives, net of reclassifications	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-293.00M	USD	2 Qtrs
Net unrealized loss on derivatives, net of reclassifications	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-375.00M	USD	2 Qtrs
Net unrealized loss on derivatives, net of reclassifications	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-143.00M	USD	1 Quarter
Net unrealized loss on derivatives, net of reclassifications	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-91.00M	USD	1 Quarter
Net unrealized gain on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$126.00M	USD	2 Qtrs
Net unrealized gain on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$35.00M	USD	1 Quarter
Net unrealized gain on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$63.00M	USD	1 Quarter
Net unrealized gain on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$78.00M	USD	2 Qtrs
Benefit plan net gain (loss) and prior service credit (cost), net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$108.00M	USD	1 Quarter
Benefit plan net gain (loss) and prior service credit (cost), net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-47.00M	USD	1 Quarter
Benefit plan net gain (loss) and prior service credit (cost), net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$136.00M	USD	2 Qtrs
Benefit plan net gain (loss) and prior service credit (cost), net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-73.00M	USD	2 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$356.00M	USD	2 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$47.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$365.00M	USD	2 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$244.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$62.00M	USD	2 Qtrs
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-14.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$132.00M	USD	2 Qtrs
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$108.00M	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$3.63B	USD	2 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$2.39B	USD	2 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$1.93B	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$1.31B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.